Arcus Biosciences Inc (RCUS)
15.07
+0.14
(+0.94%)
USD |
NYSE |
May 31, 16:00
15.07
0.00 (0.00%)
After-Hours: 20:00
Arcus Biosciences Revenue (Quarterly): 145.00M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 145.00M |
December 31, 2023 | 31.00M |
September 30, 2023 | 32.00M |
June 30, 2023 | 29.00M |
March 31, 2023 | 25.00M |
December 31, 2022 | 34.00M |
September 30, 2022 | 33.00M |
June 30, 2022 | 27.00M |
March 31, 2022 | 18.00M |
December 31, 2021 | 354.62M |
September 30, 2021 | 9.461M |
June 30, 2021 | 9.461M |
March 31, 2021 | 9.461M |
December 31, 2020 | 9.97M |
Date | Value |
---|---|
September 30, 2020 | 64.53M |
June 30, 2020 | 1.75M |
March 31, 2020 | 1.75M |
December 31, 2019 | 9.75M |
September 30, 2019 | 1.75M |
June 30, 2019 | 1.75M |
March 31, 2019 | 1.75M |
December 31, 2018 | 1.562M |
September 30, 2018 | 4.291M |
June 30, 2018 | 1.25M |
March 31, 2018 | 1.25M |
December 31, 2017 | 1.25M |
September 30, 2017 | 0.163M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.75M
Minimum
Jun 2019
354.62M
Maximum
Dec 2021
42.41M
Average
21.50M
Median
Revenue (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 11.86B |
Gilead Sciences Inc | 6.686B |
Merck & Co Inc | 15.78B |
Pfizer Inc | 14.88B |
Alnylam Pharmaceuticals Inc | 494.33M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -4.00M |
Total Expenses (Quarterly) | 141.00M |
EPS Diluted (Quarterly) | -0.05 |
Enterprise Value | 375.66M |
Profit Margin (Quarterly) | -2.76% |
Earnings Yield | -20.64% |
Normalized Earnings Yield | -19.10 |